Nuvalent (NUVL) Net Cash Flow (2020 - 2026)

Nuvalent (NUVL) posted Net Cash Flow of -$102.0 million for Q1 2026, down 169.87% on a QoQ basis from $146.0 million in Q4 2025, and down 310.41% year-over-year from $48.5 million in Q1 2025.

Nuvalent (NUVL) Net Cash Flow (2020 - 2026) Analysis & Trends

Nuvalent's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$102.0 million for Q1 2026.

  • Quarterly Net Cash Flow fell 310.41% year-over-year to -$102.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (up 74.27% YoY) and the FY2025 annual result came in at $116.1 million, up 161.18% from the prior year.
  • Net Cash Flow was -$102.0 million for Q1 2026 at Nuvalent, down from $146.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $291.5 million in Q3 2024 and bottomed at -$236.9 million in Q1 2024.
  • A 5-year average of $5.4 million and a median of -$1.3 million in 2022 frame the typical range for Net Cash Flow.
  • Peak annual rise in Net Cash Flow reached 4312.56% in 2023, while the deepest fall reached 12006.23% in 2023.
  • Nuvalent's Net Cash Flow stood at $165.5 million in 2022, then surged by 49.22% to $247.0 million in 2023, then plunged by 190.52% to -$223.6 million in 2024, then soared by 165.31% to $146.0 million in 2025, then sank by 169.87% to -$102.0 million in 2026.
  • Business Quant data shows NUVL's Net Cash Flow at -$102.0 million in Q1 2026, $146.0 million in Q4 2025, and -$11.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 10.56 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.44 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 224.46 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 57.19 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - -102.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -102.01 Mn
Mar 31, 2026 -102.01 Mn
Dec 31, 2025 145.99 Mn
Dec 31, 2025 145.99 Mn
Sep 30, 2025 -11.72 Mn
Sep 30, 2025 -11.72 Mn
Jun 30, 2025 6.64 Mn
Jun 30, 2025 6.64 Mn
Mar 31, 2025 -24.86 Mn
Mar 31, 2025 -24.86 Mn
Dec 31, 2024 -223.55 Mn
Dec 31, 2024 -223.55 Mn
Sep 30, 2024 291.54 Mn
Sep 30, 2024 291.54 Mn
Jun 30, 2024 -20.82 Mn
Jun 30, 2024 -20.82 Mn
Mar 31, 2024 -236.87 Mn
Mar 31, 2024 -236.87 Mn
Dec 31, 2023 246.95 Mn
Dec 31, 2023 246.95 Mn